Skip to content

Harrow HROW Payments to Acquire Intangible Assets

Payments to Acquire Intangible Assets at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
Organon logo
OrganonOGN
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's payments to acquire intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's payments to acquire intangible assets?
Harrow (HROW) reported payments to acquire intangible assets of $9K in Q1 2026.
How has Harrow's payments to acquire intangible assets changed year-over-year?
Harrow's payments to acquire intangible assets decreased by 78.6% year-over-year, from $42K to $9K.
What is the long-term trend for Harrow's payments to acquire intangible assets?
Over 3 years (2021 to 2024), Harrow's payments to acquire intangible assets has grown at a 0.8% compound annual growth rate (CAGR), from $84K to $86K.